The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hip Prosthesis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hip Prosthesis


High impact information on Hip Prosthesis


Chemical compound and disease context of Hip Prosthesis


Biological context of Hip Prosthesis


Anatomical context of Hip Prosthesis


Associations of Hip Prosthesis with chemical compounds

  • Dose reductions of 5-25% or 10-45% are observed in the shadow of the hip prosthesis made of 0.5-3-cm-thick titanium or steel alloy respectively [22].
  • The aim of this study was to characterise the wear particles generated from standard simulator testing and microseparation simulator testing of hot isostatically pressed (HIPed) and non-HIPed alumina ceramic-on-ceramic hip prostheses, and compare these particles to those generated in vivo [23].
  • In cemented total hip prostheses, the role of creep of the acrylic cement (polymethyl methacrylate, [PMMA]) in increasing or decreasing the chance of failure of the cement mantle is a subject of ongoing controversy [24].
  • Anaphylatoxin release in association with methylmethacrylate fixation of hip prostheses [25].
  • Nitric oxide synthase in tissues around failed hip prostheses [26].

Gene context of Hip Prosthesis


Analytical, diagnostic and therapeutic context of Hip Prosthesis


  1. Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture. Lazzerini, P.E., Capecchi, P.L., Nerucci, F., Fioravanti, A., Chellini, F., Piccini, M., Bisogno, S., Marcolongo, R., Laghi Pasini, F. Ann. Rheum. Dis. (2004) [Pubmed]
  2. Sinus histiocytosis of pelvic lymph nodes after hip replacement. A histiocytic proliferation induced by cobalt-chromium and titanium. Albores-Saavedra, J., Vuitch, F., Delgado, R., Wiley, E., Hagler, H. Am. J. Surg. Pathol. (1994) [Pubmed]
  3. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years. Lim, A.Y., Gaffney, K., Scott, D.G. Rheumatology (Oxford, England) (2005) [Pubmed]
  4. RF artifacts caused by metallic implants or instruments which get more prominent at 3 T: an in vitro study. Graf, H., Lauer, U.A., Berger, A., Schick, F. Magnetic resonance imaging. (2005) [Pubmed]
  5. Osteolysis in cemented titanium alloy hip prosthesis. Schöll, E., Eggli, S., Ganz, R. The Journal of arthroplasty. (2000) [Pubmed]
  6. Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses. Konttinen, Y.T., Li, T.F., Mandelin, J., Ainola, M., Lassus, J., Virtanen, I., Santavirta, S., Tammi, M., Tammi, R. J. Pathol. (2001) [Pubmed]
  7. Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Santavirta, S., Takagi, M., Konttinen, Y.T., Sorsa, T., Suda, A. Antimicrob. Agents Chemother. (1996) [Pubmed]
  8. Quantitative analysis of technetium-99m-methylene diphosphonate uptake in unilateral hydroxyapatite-coated total hip prostheses: first year of follow-up. Rahmy, A.I., Tonino, A.J., Tan, W.D. J. Nucl. Med. (1994) [Pubmed]
  9. Asymptomatic total hip prosthesis: natural history determined using Tc-99m MDP bone scans. Utz, J.A., Lull, R.J., Galvin, E.G. Radiology. (1986) [Pubmed]
  10. 99mTc-methylene diphosphonate bone imaging in the evaluation of total hip prostheses. Weiss, P.E., Mall, J.C., Hoffer, P.B., Murray, W.R., Rodrigo, J.J., Genant, H.K. Radiology. (1979) [Pubmed]
  11. Efficacy of alumina ceramic heads for cemented total hip arthroplasty. Saito, M., Saito, S., Ohzono, K., Takaoka, K., Ono, K. Clin. Orthop. Relat. Res. (1992) [Pubmed]
  12. Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid. Mogenet, I., Raetz-Dillon, S., Canonge, J.M., Archambaud, M., Bonnet, E. The Annals of pharmacotherapy. (2004) [Pubmed]
  13. Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacement. Planes, A., Vochelle, N., Ferru, J., Przyrowski, D., Clerc, J., Fagola, M., Planes, M. Haemostasis (1986) [Pubmed]
  14. Nocardia infection of a joint prosthesis complicating systemic lupus erythematosus. Arnal, C., Man, H., Delisle, F., M'Bappe, P., Cocheton, J.J. Lupus (2000) [Pubmed]
  15. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. Romanò, C.L., Duci, D., Romanò, D., Mazza, M., Meani, E. The Journal of arthroplasty. (2004) [Pubmed]
  16. Effect of rotation on periprosthetic bone mineral measurements in a hip phantom. Mortimer, E.S., Rosenthall, L., Paterson, I., Bobyn, J.D. Clin. Orthop. Relat. Res. (1996) [Pubmed]
  17. New insight into the mechanism of hip prosthesis loosening: effect of titanium debris size on osteoblast function. O'Connor, D.T., Choi, M.G., Kwon, S.Y., Paul Sung, K.L. J. Orthop. Res. (2004) [Pubmed]
  18. Microradiographic and histochemical evaluation of mineralization inhibition at the bone-alumina interface. Stea, S., Savarino, L., Toni, A., Sudanese, A., Giunti, A., Pizzoferrato, A. Biomaterials (1992) [Pubmed]
  19. Cathepsin K in aseptic hip prosthesis loosening: expression in osteoclasts without polyethylene wear particles. Hansen, T., Otto, M., Gaumann, A., Eckardt, A., Petrow, P.K., Delank, K.S., Kirkpatrick, C.J., Kriegsmann, J. J. Rheumatol. (2001) [Pubmed]
  20. Comparison of friction and lubrication of different hip prostheses. Scholes, S.C., Unsworth, A. Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine. (2000) [Pubmed]
  21. Extracellular matrix metalloproteinases around loose total hip prostheses. Takagi, M., Konttinen, Y.T., Santavirta, S., Sorsa, T., Eisen, A.Z., Nordsletten, L., Suda, A. Acta orthopaedica Scandinavica. (1994) [Pubmed]
  22. A study on beams passing through hip prosthesis for pelvic radiation treatment. Ding, G.X., Yu, C.W. Int. J. Radiat. Oncol. Biol. Phys. (2001) [Pubmed]
  23. Alumina-alumina artificial hip joints. Part II: characterisation of the wear debris from in vitro hip joint simulations. Tipper, J.L., Hatton, A., Nevelos, J.E., Ingham, E., Doyle, C., Streicher, R., Nevelos, A.B., Fisher, J. Biomaterials (2002) [Pubmed]
  24. Effects of cement creep on stem subsidence and stresses in the cement mantle of a total hip replacement. Lu, Z., McKellop, H. J. Biomed. Mater. Res. (1997) [Pubmed]
  25. Anaphylatoxin release in association with methylmethacrylate fixation of hip prostheses. Bengtson, A., Larsson, M., Gammer, W., Heideman, M. The Journal of bone and joint surgery. American volume. (1987) [Pubmed]
  26. Nitric oxide synthase in tissues around failed hip prostheses. Stea, S., Visentin, M., Donati, M.E., Granchi, D., Ciapetti, G., Sudanese, A., Toni, A. Biomaterials (2002) [Pubmed]
  27. Bone-resorbing cytokines in serum of patients with aseptic loosening of hip prostheses. Granchi, D., Verri, E., Ciapetti, G., Stea, S., Savarino, L., Sudanese, A., Mieti, M., Rotini, R., Dallari, D., Zinghi, G., Montanaro, L. The Journal of bone and joint surgery. British volume. (1998) [Pubmed]
  28. Autonomic neuropeptides in the interface membrane of aseptic loose hip prostheses. Ahmed, M., Bergström, J., Gillespie, W.J. The Journal of arthroplasty. (1999) [Pubmed]
  29. Cathepsin G and alpha 1-antichymotrypsin in the local host reaction to loosening of total hip prostheses. Takagi, M., Konttinen, Y.T., Santavirta, S., Kangaspunta, P., Suda, A., Rokkanen, P. The Journal of bone and joint surgery. American volume. (1995) [Pubmed]
  30. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty. Konttinen, Y.T., Waris, V., Xu, J.W., Jiranek, W.A., Sorsa, T., Virtanen, I., Santavirta, S. J. Rheumatol. (1997) [Pubmed]
  31. The plasminogen activation system is upregulated in loosening of total hip prostheses. Nordsletten, L., Buo, L., Takagi, M., Konttinen, Y.T., Yamakawa, M., Santavirta, S., Aasen, A.O. Acta orthopaedica Scandinavica. (1996) [Pubmed]
  32. Tissue reactions to wear products from polyacetal (Delrin) and UHMW polyethylene in total hip replacement. Mathiesen, E.B., Lindgren, J.U., Reinholt, F.P., Sudmann, E. J. Biomed. Mater. Res. (1987) [Pubmed]
  33. Gentamicin concentrations in diagnostic aspirates from 25 patients with hip and knee arthroplasties. Fletcher, M.D., Spencer, R.F., Langkamer, V.G., Lovering, A.M. Acta orthopaedica Scandinavica. (2004) [Pubmed]
  34. High cathepsin B activity in arthroplasty interface membranes. A histochemical study of 9 loose cemented total hip prostheses. Schüller, H.M., Scholten, P.E., Lettinga, K., Marti, R.K., Van Noorden, C.J. Acta orthopaedica Scandinavica. (1993) [Pubmed]
  35. The hydroxyapatite-ABG hip system: 5- to 7-year results from an international multicentre study. The International ABG Study Group. Tonino, A.J., Rahmy, A.I. The Journal of arthroplasty. (2000) [Pubmed]
  36. The value of (18)FDG-PET for the detection of infected hip prosthesis. Vanquickenborne, B., Maes, A., Nuyts, J., Van Acker, F., Stuyck, J., Mulier, M., Verbruggen, A., Mortelmans, L. Eur. J. Nucl. Med. Mol. Imaging (2003) [Pubmed]
WikiGenes - Universities